FDA Official Says Off-Label Ruling Won't Limit Enforcement
A U.S. Food and Drug Administration official on Wednesday maintained that the Second Circuit's decision to overturn a pharmaceutical sales representative's misbranding conviction won't change the agency's enforcement activities, saying there's...To view the full article, register now.
Already a subscriber? Click here to view full article